SOUTH SAN FRANCISCO, Calif. & SEATTLE--(BUSINESS WIRE)--Sonoma Biotherapeutics, Inc., a clinical-stage biotechnology company developing engineered regulatory T cell (T reg) therapies for ...

Sonoma Biotherapeutics, Inc., a clinical-stage biotechnology company developing engineered regulatory T cell (Treg) therapies for autoimmune and inflammatory diseases, today announced the ...

SOUTH SAN FRANCISCO, Calif. & SEATTLE--(BUSINESS WIRE)--Sonoma Biotherapeutics, Inc., a clinical-stage biotechnology company developing engineered regulatory T cell (T reg) therapies for ...

Regulatory T cell-focused Sonoma Biotherapeutics has been following a slow and steady path ever since bringing in a whopping $265 million in a 2021 fundraising round, one of the largest of the year.

Sonoma Biotherapeutics on Wednesday announced that it received a $45 million payment from Regeneron Pharmaceuticals for meeting a significant milestone in its efforts to research, develop and ...

SOUTH SAN FRANCISCO, Calif. & SEATTLE, May 06, 2025--(BUSINESS WIRE)--Sonoma Biotherapeutics, Inc., a clinical-stage biotechnology company developing engineered regulatory T cell (Treg ...

Regeneron and Sonoma Biotherapeutics have announced a partnership to identify and develop regulatory T cell (Treg) therapies for autoimmune diseases. Treg cells work by surveying the body for unwanted ...

(RTTNews) - Regeneron Pharmaceuticals, Inc. (REGN) and Sonoma Biotherapeutics, Inc. Tuesday announced partnership to discover, develop and sell T cell therapies for autoimmune diseases. As per the ...

The positions in the table below reflect the Sonoma Biotherapeutics's position overall, domestically, within their sector, and in various subject areas based on their Share. Each position links to ...

SOUTH SAN FRANCISCO, Calif. & SEATTLE, May 13, 2025--(BUSINESS WIRE)--Sonoma Biotherapeutics, Inc., a clinical-stage biotechnology company developing engineered regulatory T cell (Treg ...

Sonoma Biotherapeutics Announces Oral and Poster Presentations at the American Society of Gene and Cell Therapy (ASGCT) 28th Annual Meeting Sonoma Biotherapeutics, Inc., a clinical-stage ...

SOUTH SAN FRANCISCO, Calif. & SEATTLE-- (BUSINESS WIRE)--May 13, 2025-- ...